BIOTRON LIMITED - Announcements

20.0%

0.2¢

Market Cap $2.654M

Healthcare Biotechnology

Biotron Limited is a clinical-stage biotechnology company. The Company is engaged in the... Biotron Limited is a clinical-stage biotechnology company. The Company is engaged in the research, development, and commercialization of drugs targeting significant viral diseases with unmet medical need. The Company has BIT225 in clinical development for HIV-1 and COVID-19, and additional preclinical programs including Hepatitis B Virus (HBV). In addition, the Company has several early-stage programs designing drugs that target a class of virus protein known as viroporins, which have a key role in the virus life cycle of a range of viruses, such as Coronavirus, Dengue, Ebola, Middle East Respiratory virus, Influenza and Zika viruses. Its proprietary primary bacterial cell-based screening platform enables rapid screening of target viroporin proteins. Its lead compound, BIT225, is in Phase II development for the treatment of HIV-1. The Company also has a portfolio of preclinical antiviral programs.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

BIT	AGM Presentation		26/11/19	1.85MB	Share
BIT	Appendix 3B		21/11/19	984.03KB	Share
BIT	Option Expiry Notice		13/11/19	680.53KB	Share
BIT	Biotron Secures $5.1 Million Underwriting Agreement	PRICE SENSITIVE	08/11/19	228.04KB	Share
BIT	Change of Director's Interest Notice		07/11/19	639.96KB	Share
BIT	Appendix 3B		07/11/19	984.89KB	Share
BIT	Appendix 3B		01/11/19	1.32MB	Share
BIT	Presentation to Investors	PRICE SENSITIVE	31/10/19	980.29KB	Share
BIT	Annual Report and Notice of AGM		24/10/19	2.84MB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	21/10/19	702.34KB	Share
BIT	Appendix 3B		08/10/19	1.31MB	Share
BIT	Appointment of International Advisory Board for BIT225	PRICE SENSITIVE	01/10/19	125.89KB	Share
BIT	Appendix 3B		19/09/19	1.31MB	Share
BIT	Appendix 4G and Corporate Governance Statement		29/08/19	495.01KB	Share
BIT	Full Year Statutory Accounts	PRICE SENSITIVE	29/08/19	1.08MB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/19	702.33KB	Share
BIT	Letter to Shareholders		11/07/19	242.45KB	Share
BIT	Appendix 3B		19/06/19	1.31MB	Share
BIT	Presentation at BIO 2019	PRICE SENSITIVE	07/06/19	6.64MB	Share
BIT	Appendix 3B		07/05/19	983.88KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	11/04/19	705.54KB	Share
BIT	Appendix 3B		11/04/19	991.17KB	Share
BIT	Appendix 3B		28/03/19	991.14KB	Share
BIT	Half Yearly Report and Accounts	PRICE SENSITIVE	20/02/19	1.72MB	Share
BIT	Appendix 3B		12/02/19	993.46KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	18/01/19	690.62KB	Share
BIT	Appendix 3B		17/01/19	993.53KB	Share
BIT	Appendix 3B		07/01/19	994.15KB	Share
BIT	Appendix 3B		14/12/18	993.58KB	Share
BIT	Letter to Shareholders		12/12/18	207.28KB	Share
BIT	Exercise of Options Raises $4.7 Million		05/12/18	141.11KB	Share
BIT	Appendix 3B		30/11/18	993.21KB	Share
BIT	PRESENTATION OF BIT225-009 HIV-1 PHASE 2 DATA	PRICE SENSITIVE	28/11/18	2.91MB	Share
BIT	Change of Director's Interest Notice		23/11/18	634.21KB	Share
BIT	Appendix 3B		23/11/18	992.45KB	Share
BIT	Change of Principal Place of Business		22/11/18	222.28KB	Share
BIT	Re-Appointment of a Director		20/11/18	28.48KB	Share
BIT	Results of Meeting		20/11/18	315.44KB	Share
BIT	AGM Presentation		20/11/18	1020.79KB	Share
BIT	Appendix 3B		16/11/18	993.33KB	Share
BIT	Presentation of BIT225-009 HIV-1 Phase 2 Data		13/11/18	29.17KB	Share
BIT	Change of Director's Interest Notice		09/11/18	648.49KB	Share
BIT	Appendix 3B		09/11/18	994.12KB	Share
BIT	Change of Director's Interest Notice		02/11/18	662.66KB	Share
BIT	Appendix 3B		02/11/18	994.12KB	Share
BIT	Response to ASX aware letter	PRICE SENSITIVE	30/10/18	614.87KB	Share
BIT	Option Expiry Notice		29/10/18	538.62KB	Share
BIT	Appendix 3B		29/10/18	994.35KB	Share
BIT	Change of Director's Interest Notice		25/10/18	679.07KB	Share
BIT	Appendix 3B		25/10/18	994.29KB	Share
BIT	Presentation to Investors		25/10/18	5.67MB	Share
BIT	Appendix 3B		24/10/18	993.84KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	24/10/18	89.58KB	Share
BIT	Appendix 3B		23/10/18	994.37KB	Share
BIT	Appointment of a Director and Appendix 3X		23/10/18	31KB	Share
BIT	Appendix 3B		22/10/18	994.47KB	Share
BIT	Appendix 3B		18/10/18	993.84KB	Share
BIT	Appendix 3B		18/10/18	136.05KB	Share
BIT	Annual Report and Notice of AGM		18/10/18	7.46MB	Share
BIT	Biotron Secures $4.7 Million Underwriting Agreement	PRICE SENSITIVE	17/10/18	34.77KB	Share
BIT	$1.07 million R&D Tax Incentive Received	PRICE SENSITIVE	15/10/18	41.34KB	Share
BIT	Appendix 3B		11/10/18	418.11KB	Share
BIT	Letter to Shareholders		09/10/18	159.08KB	Share
BIT	Significant Immunological Outcomes in BIT225 HIV-1 Trial	PRICE SENSITIVE	28/09/18	406.97KB	Share
BIT	Appendix 4G and Corporate Governance Statement		29/08/18	727.19KB	Share
BIT	Full Year Statutory Accounts	PRICE SENSITIVE	29/08/18	2.02MB	Share
BIT	Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial	PRICE SENSITIVE	07/08/18	382.37KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	11/07/18	686.82KB	Share
BIT	Appendix 3B		10/07/18	902.9KB	Share
BIT	Change of Director's Interest Notice		14/06/18	690.75KB	Share
BIT	New Issue Announcement		14/06/18	1022.92KB	Share
BIT	New Issue Oversubscribed		12/06/18	289.17KB	Share
BIT	Appendix 3B		28/05/18	824.73KB	Share
BIT	Appendix 3B		16/05/18	824.75KB	Share
BIT	Letter to Eligible and Ineligible Shareholders		11/05/18	536.44KB	Share
BIT	Response to ASX Appendix 4C Query	PRICE SENSITIVE	10/05/18	986.36KB	Share
BIT	Response to ASX Price Query	PRICE SENSITIVE	10/05/18	630.61KB	Share
BIT	Prospectus	PRICE SENSITIVE	10/05/18	975.11KB	Share
BIT	Letter to Option Holders		10/05/18	549.88KB	Share
BIT	Appendix 3B		10/05/18	909.72KB	Share
BIT	Renounceable Rights Issue	PRICE SENSITIVE	10/05/18	5.54MB	Share
BIT	Trading Halt Request		08/05/18	320.51KB	Share
BIT	Trading Halt	PRICE SENSITIVE	08/05/18	67.26KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	24/04/18	686.08KB	Share
BIT	Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial	PRICE SENSITIVE	06/04/18	456.15KB	Share
BIT	Half Yearly Report and Accounts	PRICE SENSITIVE	23/02/18	322.6KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	16/01/18	87.35KB	Share
BIT	Biotron Presents to Biotech Showcase 2018		10/01/18	1.53MB	Share
BIT	Appendix 3B		08/12/17	99.29KB	Share
BIT	Results of Meeting		20/11/17	38.8KB	Share
BIT	AGM Presentation		20/11/17	1.58MB	Share
BIT	Resignation of a Director		20/11/17	35.65KB	Share
BIT	Biotron Compounds Demonstrate Activity Against HBV	PRICE SENSITIVE	15/11/17	45.29KB	Share
BIT	$1.6 Million R&D Tax Incentive Received	PRICE SENSITIVE	01/11/17	39.7KB	Share
BIT	Response to ASX Price Query	PRICE SENSITIVE	26/10/17	179.5KB	Share
BIT	Annual Report and Notice of AGM/Proxy Form		18/10/17	2.05MB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	13/10/17	162.75KB	Share
BIT	Presentation to Investors		06/10/17	2.98MB	Share
BIT	Full Year Statutory Accounts	PRICE SENSITIVE	28/08/17	585.8KB	Share
BIT	Appendix 4G and Corporate Governance Statement		28/08/17	201.92KB	Share

BIT AGM Presentation
26/11/19		1.85MB	Share
BIT Appendix 3B
21/11/19		984.03KB	Share
BIT Option Expiry Notice
13/11/19		680.53KB	Share
BIT Biotron Secures $5.1 Million Underwriting Agreement
08/11/19	PRICE SENSITIVE	228.04KB	Share
BIT Change of Director's Interest Notice
07/11/19		639.96KB	Share
BIT Appendix 3B
07/11/19		984.89KB	Share
BIT Appendix 3B
01/11/19		1.32MB	Share
BIT Presentation to Investors
31/10/19	PRICE SENSITIVE	980.29KB	Share
BIT Annual Report and Notice of AGM
24/10/19		2.84MB	Share
BIT Appendix 4C - quarterly
21/10/19	PRICE SENSITIVE	702.34KB	Share
BIT Appendix 3B
08/10/19		1.31MB	Share
BIT Appointment of International Advisory Board for BIT225
01/10/19	PRICE SENSITIVE	125.89KB	Share
BIT Appendix 3B
19/09/19		1.31MB	Share
BIT Appendix 4G and Corporate Governance Statement
29/08/19		495.01KB	Share
BIT Full Year Statutory Accounts
29/08/19	PRICE SENSITIVE	1.08MB	Share
BIT Appendix 4C - quarterly
30/07/19	PRICE SENSITIVE	702.33KB	Share
BIT Letter to Shareholders
11/07/19		242.45KB	Share
BIT Appendix 3B
19/06/19		1.31MB	Share
BIT Presentation at BIO 2019
07/06/19	PRICE SENSITIVE	6.64MB	Share
BIT Appendix 3B
07/05/19		983.88KB	Share
BIT Appendix 4C - quarterly
11/04/19	PRICE SENSITIVE	705.54KB	Share
BIT Appendix 3B
11/04/19		991.17KB	Share
BIT Appendix 3B
28/03/19		991.14KB	Share
BIT Half Yearly Report and Accounts
20/02/19	PRICE SENSITIVE	1.72MB	Share
BIT Appendix 3B
12/02/19		993.46KB	Share
BIT Appendix 4C - quarterly
18/01/19	PRICE SENSITIVE	690.62KB	Share
BIT Appendix 3B
17/01/19		993.53KB	Share
BIT Appendix 3B
07/01/19		994.15KB	Share
BIT Appendix 3B
14/12/18		993.58KB	Share
BIT Letter to Shareholders
12/12/18		207.28KB	Share
BIT Exercise of Options Raises $4.7 Million
05/12/18		141.11KB	Share
BIT Appendix 3B
30/11/18		993.21KB	Share
BIT PRESENTATION OF BIT225-009 HIV-1 PHASE 2 DATA
28/11/18	PRICE SENSITIVE	2.91MB	Share
BIT Change of Director's Interest Notice
23/11/18		634.21KB	Share
BIT Appendix 3B
23/11/18		992.45KB	Share
BIT Change of Principal Place of Business
22/11/18		222.28KB	Share
BIT Re-Appointment of a Director
20/11/18		28.48KB	Share
BIT Results of Meeting
20/11/18		315.44KB	Share
BIT AGM Presentation
20/11/18		1020.79KB	Share
BIT Appendix 3B
16/11/18		993.33KB	Share
BIT Presentation of BIT225-009 HIV-1 Phase 2 Data
13/11/18		29.17KB	Share
BIT Change of Director's Interest Notice
09/11/18		648.49KB	Share
BIT Appendix 3B
09/11/18		994.12KB	Share
BIT Change of Director's Interest Notice
02/11/18		662.66KB	Share
BIT Appendix 3B
02/11/18		994.12KB	Share
BIT Response to ASX aware letter
30/10/18	PRICE SENSITIVE	614.87KB	Share
BIT Option Expiry Notice
29/10/18		538.62KB	Share
BIT Appendix 3B
29/10/18		994.35KB	Share
BIT Change of Director's Interest Notice
25/10/18		679.07KB	Share
BIT Appendix 3B
25/10/18		994.29KB	Share
BIT Presentation to Investors
25/10/18		5.67MB	Share
BIT Appendix 3B
24/10/18		993.84KB	Share
BIT Appendix 4C - quarterly
24/10/18	PRICE SENSITIVE	89.58KB	Share
BIT Appendix 3B
23/10/18		994.37KB	Share
BIT Appointment of a Director and Appendix 3X
23/10/18		31KB	Share
BIT Appendix 3B
22/10/18		994.47KB	Share
BIT Appendix 3B
18/10/18		993.84KB	Share
BIT Appendix 3B
18/10/18		136.05KB	Share
BIT Annual Report and Notice of AGM
18/10/18		7.46MB	Share
BIT Biotron Secures $4.7 Million Underwriting Agreement
17/10/18	PRICE SENSITIVE	34.77KB	Share
BIT $1.07 million R&D Tax Incentive Received
15/10/18	PRICE SENSITIVE	41.34KB	Share
BIT Appendix 3B
11/10/18		418.11KB	Share
BIT Letter to Shareholders
09/10/18		159.08KB	Share
BIT Significant Immunological Outcomes in BIT225 HIV-1 Trial
28/09/18	PRICE SENSITIVE	406.97KB	Share
BIT Appendix 4G and Corporate Governance Statement
29/08/18		727.19KB	Share
BIT Full Year Statutory Accounts
29/08/18	PRICE SENSITIVE	2.02MB	Share
BIT Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial
07/08/18	PRICE SENSITIVE	382.37KB	Share
BIT Appendix 4C - quarterly
11/07/18	PRICE SENSITIVE	686.82KB	Share
BIT Appendix 3B
10/07/18		902.9KB	Share
BIT Change of Director's Interest Notice
14/06/18		690.75KB	Share
BIT New Issue Announcement
14/06/18		1022.92KB	Share
BIT New Issue Oversubscribed
12/06/18		289.17KB	Share
BIT Appendix 3B
28/05/18		824.73KB	Share
BIT Appendix 3B
16/05/18		824.75KB	Share
BIT Letter to Eligible and Ineligible Shareholders
11/05/18		536.44KB	Share
BIT Response to ASX Appendix 4C Query
10/05/18	PRICE SENSITIVE	986.36KB	Share
BIT Response to ASX Price Query
10/05/18	PRICE SENSITIVE	630.61KB	Share
BIT Prospectus
10/05/18	PRICE SENSITIVE	975.11KB	Share
BIT Letter to Option Holders
10/05/18		549.88KB	Share
BIT Appendix 3B
10/05/18		909.72KB	Share
BIT Renounceable Rights Issue
10/05/18	PRICE SENSITIVE	5.54MB	Share
BIT Trading Halt Request
08/05/18		320.51KB	Share
BIT Trading Halt
08/05/18	PRICE SENSITIVE	67.26KB	Share
BIT Appendix 4C - quarterly
24/04/18	PRICE SENSITIVE	686.08KB	Share
BIT Update on Progress of BIT225 Phase 2 HIV-1 Clinical Trial
06/04/18	PRICE SENSITIVE	456.15KB	Share
BIT Half Yearly Report and Accounts
23/02/18	PRICE SENSITIVE	322.6KB	Share
BIT Appendix 4C - quarterly
16/01/18	PRICE SENSITIVE	87.35KB	Share
BIT Biotron Presents to Biotech Showcase 2018
10/01/18		1.53MB	Share
BIT Appendix 3B
08/12/17		99.29KB	Share
BIT Results of Meeting
20/11/17		38.8KB	Share
BIT AGM Presentation
20/11/17		1.58MB	Share
BIT Resignation of a Director
20/11/17		35.65KB	Share
BIT Biotron Compounds Demonstrate Activity Against HBV
15/11/17	PRICE SENSITIVE	45.29KB	Share
BIT $1.6 Million R&D Tax Incentive Received
01/11/17	PRICE SENSITIVE	39.7KB	Share
BIT Response to ASX Price Query
26/10/17	PRICE SENSITIVE	179.5KB	Share
BIT Annual Report and Notice of AGM/Proxy Form
18/10/17		2.05MB	Share
BIT Appendix 4C - quarterly
13/10/17	PRICE SENSITIVE	162.75KB	Share
BIT Presentation to Investors
06/10/17		2.98MB	Share
BIT Full Year Statutory Accounts
28/08/17	PRICE SENSITIVE	585.8KB	Share
BIT Appendix 4G and Corporate Governance Statement
28/08/17		201.92KB	Share

REFRESH

First 2 3 4 5

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.2¢		Change -0.001(20.0%)		Mkt cap ! $2.654M

Open	High	Low	Value	Volume
0.3¢	0.3¢	0.2¢	$2.28K	913.3K

Buyers (Bids)

No.	Vol.	Price($)
44	34518629	0.2¢

Sellers (Offers)

Price($)	Vol.	No.
0.3¢	15608554	19

View Market Depth

No.	Vol.	Price($)
46	35768629	0.002
32	93302000	0.001
0	0	0.000
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.003	15608555	20
0.004	16987080	16
0.005	6690600	5
0.006	1200000	2
0.007	572733	2

Last trade - 16.10pm 30/07/2025 (20 minute delay)

BIT (ASX) Chart

BIOTRON LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available